Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults-Reference-Cited by-同舟云学术

Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults

Published:2022-03 Issue:3 Volume:3 Page:e173-e183
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Ahn Jin Young,Lee Jeongsoo,Suh You Suk,Song Young Goo,Choi Yoon-Jeong,Lee Kyoung Hwa,Seo Sang Hwan,Song Manki,Oh Jong-Won,Kim Minwoo,Seo Han Young,Kwak Jeong-Eun,Youn Jin Won,Woo Jung Won,Shin Eui-Cheol,Sung Young Chul,Park Su-Hyung,Choi Jun Yong

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference26 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med,2020

2. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

4. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19;Sadoff;N Engl J Med,2021

5. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma;Wibmer;Nat Med,2021

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic DNA Vaccine TargetingMycobacterium tuberculosisPersisters Shortens Curative Tuberculosis Treatment;2024-09-07

2. A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China;Frontiers in Immunology;2024-08-21

3. Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants;Science Bulletin;2024-08

4. WITHDRAWN: COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations;Life Sciences;2024-06

5. The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein;Journal of Immunology Research;2024-05-29